跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIRENA levonorgestrel 52mg intrauterine drug delivery system sachet - TGA Drug Approval Details
Approvals
/
TGA
/
MIRENA levonorgestrel 52mg intrauterine drug delivery system sachet
Approved
STANDARD
MIRENA levonorgestrel 52mg intrauterine drug delivery system sachet
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
45698d1eb3851996
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
45698d1eb3851996
Product Name
MIRENA levonorgestrel 52mg intrauterine drug delivery system sachet
Artg Id
73027
Artg Name
MIRENA levonorgestrel 52mg intrauterine drug delivery system sachet
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
2000-07-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/74bead20af168adfdc03902ad3a36299.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/22e1841fa5269399b0707a589c3a7e58.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
45698d1eb3851996
Type
Standard
Back to TGA Approvals